Newport News, VA – According to filings with the U.S. Securities and Exchange Commission, ivWatch is raising $13,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Gary Warren played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About ivWatch

Founded in 2010, ivWatch continues our mission with a singular focus to prevent patient harm by monitoring and detecting IV infiltrations. Our company and our technology have continuously evolved, developing and bringing to market the world’s first sensors and monitor that are uniquely created to detect peripheral IV infiltrations at their earliest stages. Our innovative design offers clinicians the ability to intervene well before harm can be seen by the human eye to enhance patient safety and reduce liability.

To learn more about ivWatch, visit http://www.ivwatch.com/

Contact:
Gary Warren, President and Chief Executive Officer
855-489-2824
https://www.linkedin.com/in/gary-warren-230a0a2/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved